GRI Bio enters into ATM equity offering agreement with H.C. Wainwright for up to $961,579

GRI Bio, Inc.

Company may sell up to $961,579 of common stock through H.C. Wainwright as sales agent.
Wainwright receives 3% commission on gross proceeds; no obligation for Company to sell.
Shares offered on Nasdaq as at-the-market sales under May 20, 2024 prospectus supplement.
Company can suspend or terminate the agreement at any time; $10M aggregate cap also applies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.